Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
General

Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023

  • By ICN Bureau | May 07, 2023

Tatva Chintan Pharma Chem Ltd has posted net profit of Rs. 16.95 crores for the period ended March 31, 2023 as against net profit of Rs. 11.62 crores for the period ended December 31, 2022. The company posted net profit of Rs.17.50 crores for the period ended March 31, 2022.

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023 as compared to Rs. 121.684 crores during the period ended December 31, 2022. It reported total income of Rs.98.84 crores during the period ended March 31, 2022.

For the Financial Year ended March 31, 2023, Tatva Chintan Pharma Chem has reported total income of Rs.429.35 crores as compared to Rs.442.664 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.45.48 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.95.87 crores for the Financial Year ended March 31, 2022.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Chemical

Petrochemical

Energy

Digitization